Abiomed Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Boston, MA USA
Total Funding:N/A
Industry:Medical Equip
Founded:1981
Lead Investor(s):N/A

Estimated Revenue & Financials

  • Abiomed's estimated annual revenue is currently $298.4M per year.
  • Abiomed received $41.7M in venture funding in August 2008.
  • Abiomed's estimated revenue per employee is $251,000

Employee Data

  • Abiomed has 1189 Employees.
  • Abiomed grew their employee count by 8% last year.
  • Abiomed currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
N/A6132N/AN/A-N/A
#2
$64.3M256N/AN/A-N/A
#3
N/A67N/AN/A-N/A
#4
$8.3M33N/AN/A-N/A
#5
$30.1M120N/AN/A-N/A
#6
$30.6M122N/AN/A-N/A
#7
N/A211N/AN/A-N/A
#8
N/A17N/AN/A-N/A
#9
$51.5M205N/AN/A-N/A
#10
$184.7M736N/AN/A-N/A
Missing a competitor? Contribute!?
Submit

Abiomed (NASDAQ: ABMD) is a pioneer and global leader in healthcare technology and innovation, with a mission of RECOVERING HEARTS AND SAVING LIVES. Abiomed CEO, Chairman, and President, Michael R. Minogue, has focused the company's efforts on developing ground-breaking technologies designed to assist or replace the life-sustaining pumping function of the failing heart. The Company's portfolio of products and services offer healthcare professionals an array of choices across a broad clinical spectrum. From the world's first total replacement heart to the World's Smallest Heart Pump, 1/100th the size of the heart with rapid and simple insertion, Abiomed is dedicated to finding ways to bring the most advanced and beneficial technology to patients and physicians.

keywords:Biotechnology,Healthcare,Medical Devices,Pharmaceuticals

1189

Number of Employees

$298.4M

Revenue (est)

1

Current Jobs

8%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Abiomed News

09/03/2019 - ABMD: Zhang Investor Law Announces Securities Class ...

To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=abiomed-inc&id=1981 or call Sophie Zhang, Esq. toll-free at ...

09/03/2019 - Abiomed Should Be Trading At Double Its Current Valuation

Abiomed's (ABMD) stock has seen a steady decline since last September. Back then, the stock was trading at its all-time high around $460.

09/03/2019 - SHAREHOLDER ALERT - Abiomed, Inc. (ABMD) - Bronstein ...

SHAREHOLDER ALERT - Abiomed, Inc. (ABMD) - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action and Lead Deadline: ...

Abiomed Funding

DateAmountRoundLead InvestorsReference
2008-08-25$41.7MUndisclosedMorgan Stanley and CompanyArticle

Abiomed Executive Hires

DateNameTitleReference
2001-08-07Kathleen WalshVP Human ResourcesArticle
2003-09-05Bradley GoskowiczVP MktgArticle
2004-03-17Michael GiancolaMarketing ManagerArticle
2004-04-07Michael MinogueCEO and PresidentArticle
2004-04-09Gary StickelVP of Human ResourcesArticle
2004-06-17Javier JimenezVP/OperationArticle
2004-07-23Karim BenaliVP Product DevArticle
2005-06-16Michael R. MinogueChairmanArticle
2005-07-12Jim DillonVP Eastern U.S. SalesArticle
2005-12-20Daniel J. SutherbyCFOArticle
2007-03-15Amount: 63.60Round: UndisclosedArticle
2007-04-24David WeberCOOArticle
2008-12-23Robert L. BowenVP/CFOArticle
2009-03-06Michael HowleyVP/General Manager Global Sales/MarketArticle
2012-03-22Susan Vissers LisaSr Dir Investor Relations/Corporate DeArticle
2014-09-19Ingrid GoldbergDir Investor RelationsArticle
2018-04-02Todd TrappVP & CFOArticle

Abiomed New Location/Offices

DateLocationReference
2008-08-04Boston, MAArticle
2017-04-03Boston, MAArticle

Abiomed Acquisitions

DateCompany NameAmountNotesReference
2008-08-04World Heart IncArticle